1Department of Neurosurgery, Niigata University, Japan.
Adoptive immunotherapy using lymphokine-activated killer (LAK) cells shows promise for treating experimental brain tumors in rats, significantly improving survival rates. Further research into interleukin-2 (IL-2) inhibitors is needed to enhance treatment efficacy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: